Status:
COMPLETED
Assessing Inherited Markers of Metabolic Syndrome in the Young
Lead Sponsor:
Eric Hoffman
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Howard University
Conditions:
Metabolic Syndrome
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-35 years
Brief Summary
The AIMM Young study is a collaboration between Children's National Medical Center (CNMC) and colleges/universities nationwide--currently including Howard University (HU), East Carolina University (EC...
Eligibility Criteria
Inclusion
- between the ages of 18 and 35 years
- post-puberty
- willing and able to provide informed consent
- stable medical and psychosocial status providing a high likelihood of follow-up and compliance with study protocol
- all ethnic backgrounds will be included in this study.
Exclusion
- evidence of clinically relevant systemic disease associated with disorders of glucose metabolism
- chronic use of glucocorticoid or appetite suppressants
- concomitant use of drugs known to alter glucose metabolism (i.e., metformin, thiazolidinediones, sulfonylurea receptor agonists and inhibitors of alpha-glucoside hydrolase) or other medications known to alter blood levels being tested in this study
- inability to provide the requested fasting blood sample
- pregnancy
- menopause
- alcohol dependency (as determined by CAGE screening questionnaire); (8) inability to provide informed consent
- previous diagnosis or treatment for any hematologic-oncologic disorder
- history or current treatment for an eating disorder
- current treatment for weight loss
- history of bariatric surgery
- history of neurosurgical procedure
- participation in another clinical trial involving an investigational drug
- history of psychiatric disorder, which in the opinion of the investigator would affect the conduct of the proposed trial
- age younger than 18 or older than 35 at the time of recruitment
- weight that exceeds the capacity of equipment used for weight measurements.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT00966407
Start Date
February 1 2007
End Date
December 1 2016
Last Update
February 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's National Medical Center
Washington D.C., District of Columbia, United States, 20010